World's Best Scientists 2026 revealed!
Jean-Yves Delattre

Jean-Yves Delattre

D-Index & Metrics

Medicine

D-Index
83
Citations
25352
World Ranking
15606
National Ranking
507

Jean-Yves Delattre publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jean-Yves Delattre sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 319 publications — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jean-Yves Delattre D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jean-Yves Delattre sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2017 - Grand Prix scientifique de la Fondation NRJ, Institut de France

Overview

Jean-Yves Delattre is affiliated with Université Paris Cité in France. Their research primarily focuses on Medicine, with a special emphasis on Neurology, Genetics, Radiology, Nuclear Medicine and Imaging, Epidemiology, and Cellular and Molecular Neuroscience.

The scientist's work covers a variety of key topics including:

  • Glioma Diagnosis and Treatment
  • Long-Term Effects of COVID-19
  • Autoimmune Neurological Disorders and Treatments
  • COVID-19 and Mental Health
  • Radiomics and Machine Learning in Medical Imaging
  • Intensive Care Unit Cognitive Disorders
  • Brain Metastases and Treatment

The research contributions of Jean-Yves Delattre have been published in several venues such as:

  • Neuro-Oncology
  • Nature
  • European Journal of Nuclear Medicine and Molecular Imaging
  • International Journal of Molecular Sciences
  • Brain

Recent publications include:

  • Mechanisms and therapeutic implications of hypermutation in gliomas, 2020, Nature
  • The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study, 2021, European Journal of Nuclear Medicine and Molecular Imaging
  • IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification, 2020, Neuro-Oncology
  • Neurological Syndromes Associated with Anti-GAD Antibodies, 2020, International Journal of Molecular Sciences
  • Severe COVID-19-related encephalitis can respond to immunotherapy, 2020, Brain

Frequent collaborators of Jean-Yves Delattre include:

  • Khê Hoang-Xuan
  • Dimitri Psimaras
  • Marc Sanson
  • Ahmed Idbaïh
  • Mehdi Touat

Among notable recognitions, Jean-Yves Delattre received the Grand Prix scientifique de la Fondation NRJ, Institut de France in 2017.

Best Publications

  • Recommended diagnostic criteria for paraneoplastic neurological syndromes

    F Graus;J Y Delattre;J C Antoine;J Dalmau

  • Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

    Martin J. van den Bent;Alba A. Brandes;Martin J.B. Taphoorn;Johan M. Kros

  • Radiation-induced dementia in patients cured of brain metastases.

    Lisa M. DeAngelis;Jean-Yves Delattre;Jerome B. Posner

  • Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas

    Marc Sanson;Yannick Marie;Sophie Paris;Ahmed Idbaih

  • Primary brain tumours in adults

    Anthony Behin;Khe Hoang-Xuan;Antoine F Carpentier;Jean-Yves Delattre

  • Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients

    Francesc Graus;Florence Keime-Guibert;Ramón Reñe;Baya Benyahia

  • Distribution of Brain Metastases

    Jean Yves Delattre;George Krol;Howard T. Thaler;Jerome B. Posner

  • Radiotherapy for glioblastoma in the elderly.

    Florence Keime-Guibert;Olivier Chinot;Luc Taillandier;Stéphanie Cartalat-Carel

  • Genome-wide association study identifies five susceptibility loci for glioma

    Sanjay Shete;Fay J. Hosking;Lindsay B. Robertson;Sara E. Dobbins

  • Clinical trial of blood-brain barrier disruption by pulsed ultrasound

    Alexandre Carpentier;Michael Canney;Alexandre Vignot;Vincent Reina

  • Mechanisms and therapeutic implications of hypermutation in gliomas.

    Mehdi Touat;Mehdi Touat;Mehdi Touat;Yvonne Y. Li;Yvonne Y. Li;Adam N. Boynton;Adam N. Boynton;Liam F. Spurr;Liam F. Spurr

  • IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas

    C. Houillier;X. Wang;G. Kaloshi;K. Mokhtari

  • The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20.

    T.J. Postma;N.K. Aaronson;J.J. Heimans;M.J. Muller

  • Continuous growth of mean tumor diameter in a subset of grade II gliomas.

    Emmanuel Mandonnet;Jean Yves Delattre;Marie Laure Tanguy;Kristin R. Swanson

  • A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry.

    Soufiane El Hallani;Blandine Boisselier;Florent Peglion;Audrey Rousseau

  • Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies

    I. Rojas;F. Graus;F. Keime-Guibert;R. Reñé

  • Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone

    F Keime-Guibert;F Graus;A Fleury;R René

  • Temozolomide As Initial Treatment for Adults With Low-Grade Oligodendrogliomas or Oligoastrocytomas and Correlation With Chromosome 1p Deletions

    K. Hoang-Xuan;L. Capelle;M. Kujas;S. Taillibert

  • Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.

    W P Mason;F Graus;B Lang;J Honnorat

  • Limbic encephalitis and small cell lung cancer. Clinical and immunological features.

    S Alamowitch;F Graus;M Uchuya;R Reñé

Frequent Co-Authors

Marc Sanson
Marc Sanson Sorbonne University
Ahmed Idbaih
Ahmed Idbaih Sorbonne University
Khê Hoang-Xuan
Khê Hoang-Xuan Université Paris Cité
Olivier Delattre
Olivier Delattre PSL University
Dominique Figarella-Branger
Dominique Figarella-Branger Aix-Marseille University
Stéphane Lehéricy
Stéphane Lehéricy Sorbonne University
Jérôme Honnorat
Jérôme Honnorat Hospices Civils de Lyon
François Guyot
François Guyot French National Museum of Natural History
Anthony J. Swerdlow
Anthony J. Swerdlow Institute of Cancer Research
Richard S. Houlston
Richard S. Houlston Institute of Cancer Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens up numerous related opportunities beyond traditional medical school. Many students and professionals consider nursing as a strong alternative or complementary pathway. Online learning options make nursing education more accessible, cost-effective, and flexible, allowing you to balance work and study.

If you are seeking to become a nurse practitioner, you can find affordable online fnp programs that provide high-quality training without breaking the bank. For those just starting out, a variety of online nursing courses offer convenient ways to begin or advance a nursing career.

Career advancement in nursing is also possible with further study. Ambitious professionals can choose online phd nursing programs to prepare for roles in research, teaching, or leadership. Alternatively, registered nurses with an associate degree can efficiently pursue cheap rn to bsn programs to enhance their credentials and job prospects.

These online degrees and pathways provide flexible options to grow your healthcare career—whether at the clinical, administrative, or academic level.

Best Scientists Citing Jean-Yves Delattre

Trending Scientists

Recently Published Articles